Interview by Vittoria Bellato.
Professor Gabriela Möslein is ESCP's General Secretary, Chair of the EHTG (European Hereditary Tumour Group) and Director of the Centre for Hereditary Tumours at Bethesda Hospital in Germany. She has dedicated her professional focus towards hereditary colorectal cancer both as a researcher and scientific communicator and is acknowledged worldwide for her contribution and expertise.
Interview by Zoe Garoufalia and Gloria Zaffaroni.
Lynch syndrome is characterised by predisposition to colorectal, endometrial, and other cancers, and is caused by autosomal dominant inherited pathogenic variants affecting the DNA mismatch repair (MMR) genes MLH1, MSH2, MSH6, and PMS2. It is probably the most common predisposition to cancer. Despite its high estimated prevalence, up until now, there were no reliable long term data of MMR variant carriers in order to plan their treatment according to evidence-based medicine principles.
The anticipated next instalment in the series of Johnson & Johnson Institute’s #ColorectalLive interviews will be broadcast live on Twitter this Monday 22nd June at 19.00 BST. The #ColorectalLive series is being re-launched with an exciting line-up of interviews after being postponed in March following the outbreak of the global COVID-19 pandemic.
